Recombinant Human DLK-1 protein (Fc Chimera)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human DLK-1 protein (Fc Chimera) is a Human Full Length protein, in the 1 to 303 aa range, expressed in HEK 293 cells, with >90%, < 0.01 EU/µg endotoxin level, suitable for SDS-PAGE.
View Alternative Names
DLK, DLK1, Protein delta homolog 1, DLK-1, pG2
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DLK-1 serves a function in the inhibition of adipocyte differentiation and the maintenance of preadipocyte phenotype. It does not form part of a complex but interacts with membrane-bound receptors to mediate signaling pathways that impact tissue development. Researchers study its role in embryonic development and its downregulation is a significant factor during the differentiation of mesenchymal cells. Due to these interactions DLK-1 has a pivotal involvement in processes governing tissue regeneration and growth control.
Pathways
Better understanding of DLK-1 involves examining its interaction in the Notch signaling pathway. This important pathway related to cell fate decisions features pathways with other proteins like Notch-1 and Notch-3. The relationship helps modulate the fate and proliferation of cells. DLK-1 also has associations with pathways involving phosphoinositide 3-kinase (PI3K) which influences cell growth and survival through related proteins such as AKT.
Specifications
Form
Lyophilized
General info
Function
May have a role in neuroendocrine differentiation.
Post-translational modifications
N- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com